mci 9038 has been researched along with Embolism, Pulmonary in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (9.09) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 9 (40.91) | 29.6817 |
2010's | 7 (31.82) | 24.3611 |
2020's | 4 (18.18) | 2.80 |
Authors | Studies |
---|---|
Akiyama, T; Gohma, I; Kohata, H; Kohno, M; Kumasawa, J; Nagata, T; Nishida, K; Ogawa, Y | 1 |
Daniels, LM; Sagardia, LM | 1 |
Enright, H; Fahy, A; McGlynn, F; McGrath, J; McHugh, J; Ryan, B; Varghese, C | 1 |
Gandotra, P; Garra, G; Gruberg, L; Selim, S; Supariwala, A | 1 |
Ahmed, MI; Bethea, BT; Elliot, JW; Richardson, JB | 1 |
Gamberini, L; Laici, C; Loforte, A; Ravaioli, M; Siniscalchi, A | 1 |
Dai, G; Liu, Q; Sun, L; Wang, C | 1 |
Pötzsch, B | 1 |
Burger, CF; Schlesinger, JJ | 1 |
Bhalla, MC; Frey, JA; Hourmouzis, Z; Jwayyed, S | 1 |
Jiji, RS; Michaels, AD | 1 |
Fries, D | 1 |
Knovich, MA; Lesser, GJ; Strowd, RE | 1 |
Ahmed, S; Karim, A; Mattana, J; Patel, D; Siddiqui, R | 1 |
Aizawa, Y; Fuse, I; Hanzawa, K; Hayashi, J; Higuchi, K; Hori, T; Matsubara, T; Mezaki, T; Moro, H; Nasuno, A; Tanaka, K; Tanaka, T; Tsuchida, K | 1 |
Hayashi, T; Kaneko, M; Nakao, Y; Nomura, T; Nonaka, Y; Okamura, J; Suyama, Y | 1 |
Hursting, MJ; Kelton, JG; Lewis, BE; Matthai, WH | 1 |
Rice, L | 1 |
Kaneko, M; Kohno, H; Muraoka, M; Shikata, H | 1 |
Durr, EA; Krueger, CD; Shapiro, NL | 1 |
Abiko, Y; Kumada, T | 1 |
Abiko, Y; Hara, T; Iwamoto, M; Kumada, T; Ogawa, H; Tomikawa, M | 1 |
3 review(s) available for mci 9038 and Embolism, Pulmonary
Article | Year |
---|---|
[Anticoagulation].
Topics: Administration, Oral; Anticoagulants; Antithrombins; Arginine; Arrhythmias, Cardiac; Blood Coagulation Tests; Factor Xa Inhibitors; Hemorrhage; Heparin; Heparinoids; Hirudins; Humans; Infusions, Intravenous; Orthopedic Procedures; Peptide Fragments; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Risk Factors; Secondary Prevention; Sulfonamides; Thromboembolism; Treatment Outcome; Venous Thrombosis; Vitamin K | 2013 |
[Anticoagulation in critically ill patient].
Topics: Anticoagulants; Arginine; Biological Availability; Blood Coagulation Tests; Contraindications; Critical Care; Drug Monitoring; Heparin; Heparin, Low-Molecular-Weight; Humans; Pipecolic Acids; Pulmonary Embolism; Risk Factors; Sepsis; Shock, Septic; Sulfonamides; Venous Thrombosis | 2009 |
Evolving management strategies for heparin-induced thrombocytopenia.
Topics: Anticoagulants; Arginine; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Warfarin | 2005 |
1 trial(s) available for mci 9038 and Embolism, Pulmonary
Article | Year |
---|---|
Argatroban anticoagulation in patients with a history of heparin-induced thrombocytopenia.
Topics: Adult; Aged; Aged, 80 and over; Arginine; Coronary Disease; Female; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Venous Thrombosis | 2005 |
18 other study(ies) available for mci 9038 and Embolism, Pulmonary
Article | Year |
---|---|
Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019.
Topics: Adult; Anticoagulants; Antithrombins; Arginine; Betacoronavirus; Blood Coagulation; Coronavirus Infections; COVID-19; Heparin; Host-Pathogen Interactions; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombocytopenia; Treatment Outcome | 2020 |
Thrombolysis and use of argatroban for the treatment of massive pulmonary embolism following anticoagulation failure in a patient with COVID-19.
Topics: Adult; Anticoagulants; Arginine; Coronavirus Infections; COVID-19; Fibrinolytic Agents; Heart Arrest; Heparin, Low-Molecular-Weight; Humans; Male; Pandemics; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; Sulfonamides; Thrombolytic Therapy; Treatment Failure; Treatment Outcome | 2020 |
Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection.
Topics: Adult; Anticoagulants; Arginine; Catheter Obstruction; COVID-19; Drug Resistance; Drug Substitution; Fibrin Fibrinogen Degradation Products; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Respiration, Artificial; SARS-CoV-2; Sulfonamides; Thrombosis; Tomography, X-Ray Computed; Treatment Outcome | 2021 |
Aortic Arch Thrombus and Pulmonary Embolism in a COVID-19 Patient.
Topics: Anticoagulants; Antithrombins; Aorta, Thoracic; Arginine; Biomarkers; COVID-19; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pneumonia, Viral; Pulmonary Embolism; SARS-CoV-2; Sulfonamides; Thrombosis | 2021 |
Treatment of pulmonary embolism with argatroban and ultrasound-assisted catheter-directed thrombolysis with alteplase in a patient with heparin-induced thrombocytopenia.
Topics: Aged; Arginine; Catheterization; Drug Therapy, Combination; Female; Fibrinolytic Agents; Heparin; Humans; Pipecolic Acids; Platelet Aggregation Inhibitors; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Treatment Outcome; Ultrasonography, Interventional | 2017 |
Thrombolysis for acute pulmonary embolism after major hepatic surgery.
Topics: Acute Disease; Adenocarcinoma; Appendiceal Neoplasms; Arginine; Atrial Fibrillation; Bronchoscopy; Catheters; Colectomy; Computed Tomography Angiography; Diagnosis, Differential; Electric Countershock; Fibrinolytic Agents; Heparin; Hepatectomy; Humans; Infusions, Intravenous; Intubation, Intratracheal; Liver Neoplasms; Lung; Male; Middle Aged; Pipecolic Acids; Postoperative Complications; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombolytic Therapy; Tissue Plasminogen Activator; Troponin I; Ultrasonography; Venous Thrombosis | 2017 |
Application of thrombelastography in primary total knee and total hip replacement: a prospective 87 patients study.
Topics: Anticoagulants; Arginine; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Female; Humans; Male; Middle Aged; Partial Thromboplastin Time; Perioperative Care; Pipecolic Acids; Postoperative Care; Preoperative Care; Prospective Studies; Prothrombin Time; Pulmonary Embolism; Rivaroxaban; Sulfonamides; Thrombelastography; Thrombophilia; Venous Thrombosis | 2019 |
Intravenous warfarin and heparin-induced thrombocytopenia: making the diagnosis, management, modern monitoring, and multidisciplinary care.
Topics: Aged; Anticoagulants; Antithrombins; Arginine; Cardiac Surgical Procedures; Hemorrhage; Heparin; Humans; Infusions, Intravenous; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Thrombosis; Warfarin | 2014 |
Pulmonary embolism and heparin-induced thrombocytopenia successfully treated with tissue plasminogen activator and argatroban.
Topics: Antithrombins; Arginine; Female; Fibrinolytic Agents; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tissue Plasminogen Activator | 2015 |
Heparin-induced thrombocytopenia (HIT) causing pulmonary emboli during coronary intervention.
Topics: Aged; Angina Pectoris; Angioplasty, Balloon, Coronary; Anticoagulants; Arginine; Combined Modality Therapy; Coronary Angiography; Coronary Stenosis; Disseminated Intravascular Coagulation; Embolectomy; Heparin; Humans; Male; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Tomography, X-Ray Computed; Vena Cava Filters | 2008 |
The therapeutic management of bleeding and thrombotic disorders complicating CNS malignancies.
Topics: Antibodies, Monoclonal, Humanized; Anticoagulants; Arginine; Bevacizumab; Central Nervous System Neoplasms; Fondaparinux; Glioblastoma; Glioma; Hemorrhage; Heparin, Low-Molecular-Weight; Hirudins; Humans; Pipecolic Acids; Polysaccharides; Postoperative Complications; Pulmonary Embolism; Recombinant Proteins; Sulfonamides; Thrombocytopenia; Vena Cava Filters; Venous Thromboembolism; Venous Thrombosis; Warfarin | 2012 |
Low-molecular weight heparin: treatment failure in a patient with primary antiphospholipid antibody syndrome.
Topics: Adolescent; Anticoagulants; Antiphospholipid Syndrome; Arginine; Arm; Enoxaparin; Female; Folic Acid; Heparin, Low-Molecular-Weight; Humans; International Normalized Ratio; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Treatment Failure; Treatment Outcome; Venous Thrombosis; Warfarin | 2002 |
Acute pulmonary thromboembolism induced by prophylactic heparin use and a heparin-coated catheter: a case of heparin-induced thrombocytopenia and thrombosis syndrome.
Topics: Acute Disease; Anticoagulants; Arginine; Catheterization; Catheterization, Central Venous; Coated Materials, Biocompatible; Female; Heparin; Humans; Middle Aged; Pipecolic Acids; Pulmonary Embolism; Radionuclide Imaging; Sulfonamides; Syndrome; Thrombocytopenia; Thromboembolism; Tomography, X-Ray Computed; Ultrasonography | 2003 |
Heparin-induced thrombocytopenia and thrombosis in a patient with polycythemia vera.
Topics: Aged; Arginine; Female; Follow-Up Studies; Heparin; Humans; Japan; Pipecolic Acids; Polycythemia Vera; Pulmonary Embolism; Risk Assessment; Severity of Illness Index; Sulfonamides; Thrombocytopenia; Thrombosis; Treatment Outcome | 2004 |
[Two cases of heparin-induced thrombocytopenia (HIT) and a review of the literature].
Topics: Aged; Antibodies; Arginine; Female; Heart Failure; Heparin; Humans; Male; Middle Aged; Pipecolic Acids; Platelet Factor 4; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Prolonged anticoagulation after discontinuation of argatroban and warfarin therapy in an obese patient with heparin-induced thrombocytopenia.
Topics: Adult; Anticoagulants; Arginine; Drug Therapy, Combination; Female; Gastric Bypass; Heparin; Humans; International Normalized Ratio; Obesity, Morbid; Partial Thromboplastin Time; Pipecolic Acids; Pulmonary Embolism; Sulfonamides; Thrombocytopenia; Treatment Outcome; Warfarin | 2006 |
Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
Topics: Acute Disease; Animals; Antibodies, Anti-Idiotypic; Antigens; Antithrombin III; Arginine; Blood Coagulation Tests; Fibrinolytic Agents; Heparin; Male; Mice; Mice, Inbred Strains; Pipecolic Acids; Pulmonary Embolism; Rabbits; Rats; Rats, Inbred Strains; Sulfonamides; Thrombin; Thrombophlebitis | 1981 |
[Preventive effects of synthetic antithrombin, MD-805, on animal thrombosis models].
Topics: Acute Disease; Animals; Antithrombin III Deficiency; Antithrombins; Arginine; Arterial Occlusive Diseases; Mice; Pipecolic Acids; Pulmonary Embolism; Rats; Rats, Inbred Strains; Sulfonamides; Thrombosis; Vena Cava, Inferior | 1987 |